Arcellx (ACLX) EBIT (2021 - 2025)

Arcellx's quarterly EBIT came in at $237.5 million in Q4 2025, up 546.74% year-on-year from $36.7 million in Q4 2024, and up 484.38% quarter-over-quarter from -$61.8 million in Q3 2025.

Arcellx has reported EBIT for 5 years, with the latest figure at $237.5 million in Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 546.74% year-over-year to $237.5 million; the trailing twelve-month figure through Dec 2025 stood at $48.1 million (up 134.93% YoY), and the FY2025 full-year result was $48.1 million, up 134.93% from the prior year.
  • EBIT for Q4 2025 stood at $237.5 million, up from -$61.8 million in the prior quarter.
  • The five-year high for EBIT was $237.5 million in Q4 2025, with the low at -$93.9 million in Q3 2022.
  • Average EBIT over 5 years is -$21.8 million, with a median of -$30.9 million recorded in 2022.
  • Year-over-year, EBIT sank 454.37% in 2024 and jumped 546.74% in 2025.
  • Tracing ACLX's EBIT over 5 years: stood at -$20.7 million in 2021, then plunged by 93.27% to -$40.0 million in 2022, then soared by 137.49% to $15.0 million in 2023, then slumped by 454.37% to -$53.2 million in 2024, then jumped by 546.74% to $237.5 million in 2025.
  • The last three EBIT figures came in at $237.5 million (Q4 2025), -$61.8 million (Q3 2025), and -$58.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -19.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.14 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 642.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 268.64 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 237.45 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 237.45 Mn
Sep 30, 2025 -61.78 Mn
Jun 30, 2025 -58.73 Mn
Mar 31, 2025 -68.90 Mn
Dec 31, 2024 -53.15 Mn
Sep 30, 2024 -33.62 Mn
Jun 30, 2024 -34.99 Mn
Mar 31, 2024 -15.81 Mn
Dec 31, 2023 15.00 Mn
Sep 30, 2023 -44.86 Mn
Jun 30, 2023 -29.56 Mn
Mar 31, 2023 -30.46 Mn
Dec 31, 2022 -40.00 Mn
Sep 30, 2022 -93.88 Mn
Jun 30, 2022 -31.29 Mn
Mar 31, 2022 -26.09 Mn
Dec 31, 2021 -20.70 Mn
Sep 30, 2021 -17.11 Mn
Jun 30, 2021 -15.93 Mn
Mar 31, 2021 -11.28 Mn